STOCK TITAN

Hims & Hers To Expand UK Footprint, Acquire London-Based Honest Health

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Rhea-AI Summary

Hims & Hers Health announces its strategic acquisition of Honest Health, a UK-based health platform specializing in hair loss products. This deal aims to bolster Hims & Hers' operational capabilities and support its expansion into the UK and Western Europe. Honest Health, founded in 2018, offers innovative health solutions through a partnership with a UK compounding pharmacy. The acquisition is expected to close in the second fiscal quarter of 2021, aligning with Hims & Hers' mission to enhance personalized healthcare experiences for consumers.

Positive
  • Acquisition of Honest Health enhances operational capabilities and facilitates UK expansion.
  • Strategic fit with Hims & Hers' mission to provide personalized healthcare.
  • Access to an established platform for hair loss treatment in the UK market.
Negative
  • Financial details of the transaction remain undisclosed, raising transparency concerns.
  • Potential risks associated with consumer acceptance and changes in demand for products.

Hims & Hers Health, Inc., the multi-specialty telehealth platform focused on providing modern personalized health and wellness experiences to all consumers, today announced plans to expand their UK footprint and acquire London-based vertical health platform, Honest Health. Honest Health offers consumers hair loss-related products, including access to compounded products, such as a topical Finasteride with Minoxidil solution when appropriate, through an exclusive relationship with the first UK compounding pharmacy and fulfillment center. The proposed transaction provides Hims & Hers with best-in-class operational capability and infrastructure to support the beginnings of the Company’s long-term plans for expansion across the United Kingdom and Western Europe. Financial details of the transaction will not be disclosed at this time.

“Honest Health has demonstrated a powerful combination of leadership, passion and innovation in digital health -- at scale -- that will further elevate our ability to provide the Hims & Hers personalized healthcare experience to a new segment of consumers in the United Kingdom,” said Andrew Dudum, CEO and co-founder of Hims & Hers. “Adding Honest Health to our family not only perfectly aligns with our mission but also unlocks new category and geographic opportunities to even further accelerate growth. We are thrilled to have the Honest Health team join the Hims & Hers family.”

Honest Health, founded by Sam Gluck and Pavlo Maherovsky, launched in November 2018 with Freshman, its next generation hair loss virtual clinic for men.

“Since launching Honest Health in the UK two and a half years ago, we have been dedicated to demolishing the obstacles standing between people and better health,” said Gluck. “We are excited to join the Hims & Hers team to take this mission of healthcare access and personalization for all to the next level.”

The deal is expected to close during the second fiscal quarter of this year.

Forward Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “believes,” “estimates,” “anticipates,” “expects,” “intends,” “plans,” “may,” “will,” “potential,” “projects,” “predicts,” “continue,” or “should,” or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to the Company’s expansion plans, the Company’s ability to consummate the anticipated transaction, the ability of Honest Health to distribute products outside the UK, and the anticipated impacts of the transaction on the Company’s business. These statements are based on management’s current expectations, but actual results may differ materially due to various factors. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future.

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, risks associated with Honest Health’s ongoing operations; the possibility that the acquisition will not occur; the possibility that the expected benefits of the acquisition are not realized when expected or at all; and consumer acceptance and changes in demand for Honest Health’s and the Company's products, as well as those factors described in the “Risk Factors” section of the Company’s most recently filed Quarterly Report on Form 10-Q for the three months ended March 31, 2021, and our subsequent filings with the Securities and Exchange Commission.

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

About Hims & Hers

Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to primary care, mental health, sexual health, dermatology, and more. Launched in November 2017, the company also offers thoughtfully created and curated health and wellness products. With products and services available across all 50 states and Washington, D.C., Hims & Hers is able to provide access to quality, convenient and affordable care for all Americans. Hims & Hers was founded by CEO Andrew Dudum, Hilary Coles, Jack Abraham and Joe Spector at venture studio Atomic in San Francisco, California. LionTree Advisors served as exclusive financial advisor to Hims & Hers. For more information about Hims & Hers, please visit forhims.com and forhers.com.

FAQ

What is the significance of Hims & Hers acquiring Honest Health?

The acquisition enhances Hims & Hers' operational capabilities and facilitates expansion into the UK market.

When is the acquisition of Honest Health expected to close?

The deal is anticipated to close during the second fiscal quarter of 2021.

What products does Honest Health offer?

Honest Health specializes in hair loss-related products, including compounded solutions.

How does this acquisition align with Hims & Hers' goals?

It aligns with their mission to provide personalized healthcare experiences to a broader consumer base.

Are there any risks associated with this acquisition?

Yes, risks include consumer acceptance and potential changes in demand for the products offered.

Hims & Hers Health, Inc.

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Stock Data

5.76B
184.42M
11.37%
65.88%
18.09%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States of America
SAN FRANCISCO